Ayurcann Holdings Statistics

Total Valuation

Ayurcann Holdings has a market cap or net worth of CAD 6.81 million. The enterprise value is 7.32 million.

Market Cap	6.81M
Enterprise Value	7.32M

Important Dates

The last earnings date was Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Ayurcann Holdings has 194.70 million shares outstanding. The number of shares has increased by 18.17% in one year.

Current Share Class	n/a
Shares Outstanding	194.70M
Shares Change (YoY)	+18.17%
Shares Change (QoQ)	+0.93%
Owned by Insiders (%)	47.96%
Owned by Institutions (%)	n/a
Float	65.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.25
PB Ratio	12.74
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.84
EV / Sales	0.29
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.69

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 1.67.

Current Ratio	0.85
Quick Ratio	0.41
Debt / Equity	1.67
Debt / EBITDA	n/a
Debt / FCF	-1.67
Interest Coverage	-4.53

Financial Efficiency

Return on equity (ROE) is -245.88% and return on invested capital (ROIC) is -94.44%.

Return on Equity (ROE)	-245.88%
Return on Assets (ROA)	-14.73%
Return on Capital (ROIC)	-94.44%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.82
Inventory Turnover	3.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +133.33% in the last 52 weeks. The beta is 1.76, so Ayurcann Holdings's price volatility has been higher than the market average.

Beta (5Y)	1.76
52-Week Price Change	+133.33%
50-Day Moving Average	0.04
200-Day Moving Average	0.04
Relative Strength Index (RSI)	42.69
Average Volume (20 Days)	31,360

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ayurcann Holdings had revenue of CAD 25.16 million and -3.97 million in losses. Loss per share was -0.02.

Revenue	25.16M
Gross Profit	8.00M
Operating Income	-3.25M
Pretax Income	-3.97M
Net Income	-3.97M
EBITDA	-2.17M
EBIT	-3.25M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 389,092 in cash and 894,643 in debt, giving a net cash position of -505,551 or -0.00 per share.

Cash & Cash Equivalents	389,092
Total Debt	894,643
Net Cash	-505,551
Net Cash Per Share	-0.00
Equity (Book Value)	534,878
Book Value Per Share	0.00
Working Capital	-2.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -96,894 and capital expenditures -437,944, giving a free cash flow of -534,838.

Operating Cash Flow	-96,894
Capital Expenditures	-437,944
Free Cash Flow	-534,838
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 31.82%, with operating and profit margins of -12.92% and -15.77%.

Gross Margin	31.82%
Operating Margin	-12.92%
Pretax Margin	-15.77%
Profit Margin	-15.77%
EBITDA Margin	-8.62%
EBIT Margin	-12.92%
FCF Margin	-2.13%

Dividends & Yields

Ayurcann Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.17%
Shareholder Yield	-18.17%
Earnings Yield	-63.90%
FCF Yield	-7.85%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ayurcann Holdings has an Altman Z-Score of -0.33. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.33
Piotroski F-Score	n/a